Closed MRI Systems Market Analysis & Forecast: 2026-2033
The Closed MRI Systems Market size is anticipated to grow at a CAGR of 6.6% with USD 5.7 Bn in 2026 and is expected to reach USD 8.9 Bn in 2033. The primary drivers are defined by the growing burden of neurological disorders, cancer, cardiovascular conditions, musculoskeletal injuries, and age-related diseases, alongside expanding hospital infrastructure, rising demand for high-resolution imaging, and adoption of helium-efficient, AI-enabled closed MRI platforms. According to WHO, more than 3 billion people worldwide are living with a neurological condition, thereby highlighting the substantial need for accurate diagnostic imaging, disease monitoring, treatment planning, and advanced closed MRI capacity across developed and emerging healthcare systems.
On the basis of strength of magnetic field, the 1.5 tesla segment is projected to account for the largest Closed MRI Systems Market share of 47.8% in 2026. The segment’s growth is owing to the ability to offer an established balance between image quality, examination speed, acquisition cost, power consumption, infrastructure requirements, and clinical flexibility.
In January 2026, Siemens Healthineers received FDA clearance for its 70-centimeter MAGNETOM Flow 1.5T platform. The system uses only 0.7 liters of liquid helium and eliminates the conventional quench pipe. Siemens has also stated that its energy management technologies can reduce annual consumption compared with earlier system generations.
To learn more about this report, Request Free Sample
On the basis of application, the brain segment lead with a major 28.4% share in 2026. The growth is owing to the high prevalence of neurological disorders, growing stroke and dementia incidence, increasing use of MRI in tumor characterization, and broader adoption of diffusion, perfusion, functional, and spectroscopy protocols.
According to the World Health Organization, neurological disorders are responsible for more than 11 million deaths annually. Dementia alone affected approximately 57 million people, while nearly 10 million new dementia cases occur each year. These figures indicate a sustained diagnostic requirement for brain MRI across emergency care, neurology, oncology, geriatrics, pediatrics, and neurodegenerative disease management.
The United States represents a major center for closed MRI innovation because of its extensive hospital network, high imaging intensity, established research ecosystem, and relatively rapid adoption of advanced radiology technologies. Manufacturers are introducing sealed magnets, wide-bore architectures, automated scan planning, deep-learning reconstruction, motion correction, and energy-management functions. These features improve image quality, reduce repeat scans, simplify patient positioning, and expand access to MRI in facilities where conventional helium-intensive systems may be difficult to install. OECD assessments also identify the U.S. as having one of the highest MRI equipment densities among member countries.
In February 2026, GE HealthCare received U.S. FDA clearances for SIGNA Sprint with Freelium, SIGNA Bolt, and SIGNA One. SIGNA Sprint incorporates a sealed 1.5T magnet designed to reduce dependence on helium, while SIGNA Bolt is a next-generation 3T platform intended for high-performance clinical and research imaging. SIGNA One integrates workflow tools across the imaging pathway. GE HealthCare stated that these clearances support its strategy around sustainability, productivity, advanced diagnostics, and modernization of its MRI portfolio.
Conventional superconducting closed MRI systems have historically required large quantities of liquid helium to maintain the magnet at extremely low temperatures. This creates installation requirements, quench-pipe infrastructure, refill risks, supply exposure, and lifecycle expenses. Helium-independent and sealed-for-life magnet technologies address these constraints by permanently containing a much smaller volume of helium within the magnet. The resulting systems can be lighter, easier to site, less dependent on specialized infrastructure, and more suitable for community hospitals or diagnostic centers with limited installation space.
In November 2025, Philips unveiled BlueSeal Horizon, the first helium-free 3.0T MRI innovation platform. The system combines a sealed 3T magnet with AI-supported clinical and workflow capabilities for neurological, vascular, musculoskeletal, as well as complex whole-body imaging. The firm identified the platform as a work in progress, meaning commercial availability remained subject to regulatory and market requirements.
|
Current Event |
Description and its Impact |
|
2026 FDA Quality Management System Regulation Implementation in the U.S.
|
|
|
2025 FDA Cybersecurity Guidance for Connected Medical Devices |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
To learn more about this report, Request Free Sample
The North America region accounts for 37.8% of the market share in 2026. The region’s growth is owing to the high diagnostic-imaging volumes, replacement of aging scanners, hospital investment in advanced 1.5T and 3.0T platforms, and persistent capacity gaps.
Canadian Institute for Health Information data show that Canada completed 16% more MRI and CT scans in 2024 than in 2019, indicating rising utilization across provincial health systems. However, access constraints remain substantial. The CIHI reported in June 2026 that one in ten Canadians requiring an MRI waited more than 200 days, thereby reinforcing the need for additional closed-bore MRI capacity and faster workflows.
In July 2023, Fujifilm received FDA 510(k) clearance for ECHELON Synergy, its 1.5T closed MRI system featuring a 70 cm horizontal bore. The system incorporates deep-learning reconstruction, automated patient positioning, flexible coils, accelerated acquisition, and workflow functions designed to improve image quality, examination efficiency, and patient comfort.
Asia Pacificis expected to witness strong growth in market over the forecast period. The region’s growth is owing to the hospital construction, rising insurance penetration, increasing neurological and cancer burdens, aging populations, urban diagnostic-center expansion, and efforts to improve access to advanced medical imaging.
OECD data indicate that Japan has approximately 57 MRI units per million population, while Cambodia, Pakistan, Myanmar, the Philippines, Sri Lanka, and Bangladesh report fewer than one unit per million. This substantial gap demonstrates both regional inequality and long-term equipment potential.
The region is also becoming an important MRI innovation and manufacturing center. United Imaging Healthcare reported research and development expenditure of CNY 2.26 billion in 2024, an increase of 17.84% year over year. The company’s portfolio includes 1.5T, 3T, and 5T MRI systems and AI-supported imaging technologies.
In the United States, the Closed MRI Systems Market is influenced by the high diagnostic utilization, extensive hospital infrastructure, and continued replacement of aging scanners. The American Hospital Association’s 2026 Fast Facts reported 35.7 million hospital admissions, thereby indicating a substantial patient base requiring neurological, musculoskeletal, cardiac, abdominal, as well as oncology imaging.
In June 2025, the U.S. FDA cleared Siemens Healthineers’ MAGNETOM Flow.Ace and MAGNETOM Flow.Plus, both 1.5T, 60-centimeter-bore MRI systems. The sealed, quench-pipe-free magnets and workflow technologies can simplify installation, improve operational efficiency, and encourage hospitals and outpatient imaging centers to expand or modernize closed MRI capacity nationwide over coming years.
China is emerging as a major growth market for Closed MRI Systems. The growth is owing to the expanding healthcare infrastructure, rising demand for advanced cancer and neurological imaging, and domestic innovation in high-field scanners. By the end of 2025, China had 1.108 million medical and health institutions, thereby supporting the broader installation opportunities across hospitals as well as diagnostic centers.
In February 2025, Fudan University Shanghai Cancer Center launched a full-body 5.0T MRI scanner for ultra-high-resolution tumor imaging. The system improves visualization of tumor boundaries, internal structures, and surrounding tissues, strengthening precision diagnosis and research while encouraging hospitals to upgrade conventional closed MRI platforms nationwide more rapidly.
Some of the major key players in Closed MRI Systems Market are Hitachi, Siemens Healthineers, Canon Medical Systems, GE Healthcare, Philips, Aspect Imaging, Bruker, Aurora Imaging Technology and Esaote S.P.A.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.7 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.6% | 2033 Value Projection: | USD 8.9 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Hitachi, Siemens Healthineers, Canon Medical Systems, GE Healthcare, Philips, Aspect Imaging, Bruker, Aurora Imaging Technology and Esaote S.P.A. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
